Today: 10 June 2026
Lemonade stock rises again premarket as Tesla FSD insurance discount grabs attention

Lemonade stock rises again premarket as Tesla FSD insurance discount grabs attention

New York, Jan 22, 2026, 07:18 ET — Premarket

  • Lemonade shares climbed roughly 2.5% in premarket, following a 9% surge the day before.
  • The insurer rolled out a new “Autonomous Car” policy linked directly to Tesla’s Full Self-Driving mileage.
  • A JPMorgan filing revealed the bank’s stake had crossed the 5% disclosure mark.

Lemonade shares climbed 2.5% to $87.50 in premarket trading Thursday, following a 9.1% jump to $85.36 at Wednesday’s close.

This shift is significant, thrusting a modest insurer still operating at a loss into a larger conversation: how should car risk be priced as software takes over driving duties, and who should reap the rewards for improved safety — the driver, the automaker, or the insurer?

It comes as investors rush to snap up any fresh growth opportunity in auto insurance—a sector where pricing errors might not surface in claims for years.

Lemonade has introduced “Autonomous Car” insurance specifically for Tesla vehicles using Full Self-Driving, slashing per-mile rates for FSD-engaged driving by roughly 50%. The company credits a technical partnership that grants access to vehicle data. “Teslas driven with FSD are involved in far fewer accidents,” said Shai Wininger, co-founder and president. He added, “Traditional insurers treat a Tesla like any other car, and AI like any other driver.” The product will start rolling out in Arizona on Jan. 26 and expand to Oregon about a month later. Business Wire

The discount is connected to Lemonade’s pay-per-mile insurance, where premiums fluctuate based on how much the customer drives. Tesla will supply telemetry data to distinguish miles driven by the system from those driven by the driver. Tesla already offers its own insurance in select markets and gives discounts tied to driver-assistance feature usage. Meanwhile, U.S. safety regulators have examined crashes and other incidents involving the FSD system, which still requires driver supervision.

JPMorgan Chase & Co disclosed owning 4,482,950 shares of Lemonade, representing 5.9% of the class, in a Schedule 13G filing dated Dec. 31, 2025. The 13G indicates these holdings are in the ordinary course, not part of an activist effort to gain control.

Lemonade’s stock has been all over the place this month, currently hovering near the upper end of its 52-week range, which MarketWatch puts between $24.31 and $88.88.

But the positive spin on “safer miles” faces tough scrutiny: can the loss data really hold steady across different states, weather, and driving conditions? And what happens if regulators tighten their grip on driver-assist systems? Lemonade’s trailing EPS is still in the red, and the company hasn’t announced its next earnings date. MarketBeat projects the report will drop before the open on Feb. 24, based on previous schedules. MarketBeat

Traders now face an immediate test: will demand pick up when Arizona’s rollout begins Jan. 26? Then February’s Oregon expansion will need to align smoothly on pricing and underwriting to keep momentum.

Investors will also track any updates on the product itself — including take-up rates, loss trends, and the treatment of FSD miles by Lemonade — when the company reports results, likely around Feb. 24.

Stock Market Today

  • Palantir Technologies (PLTR) Shares Seen Fairly Valued Amid Recent Decline
    June 10, 2026, 5:48 PM EDT. Palantir Technologies has seen its share price fall 13.2% over the past week and 21.3% year to date, following extraordinary gains in prior years. At $132.07 per share, Palantir trades slightly below its estimated intrinsic value of $145.11 based on a Discounted Cash Flow (DCF) analysis, suggesting a modest 9% discount. The company posted $2.69 billion in free cash flow over the past twelve months, with projections rising to $16.11 billion by 2030. Despite recent volatility tied to sentiment on artificial intelligence and software spending, Palantir remains fairly valued but not a clear bargain. Investors should monitor further market developments and valuation metrics to gauge future opportunities or risks.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Vertex stock jumps 4% as earnings date nears — what traders watch next for VRTX
Previous Story

Vertex stock jumps 4% as earnings date nears — what traders watch next for VRTX

Salesforce stock rebounds as Dow firms; Benioff’s Davos AI warning keeps CRM in focus
Next Story

Salesforce stock rebounds as Dow firms; Benioff’s Davos AI warning keeps CRM in focus

Go toTop